OVERVIEW

Join us on October 10th at 4:00PM EST for an engaging 1-hour webinar with Dr. Ildiko Lingvay, who will provide an in-depth discussion on the SELECT trial. This landmark study examines the cardiovascular outcomes of obesity management interventions. Dr. Lingvay will explore the trial’s design, key findings, and its potential to reshape clinical approaches for patients with obesity and heightened cardiovascular risk. Attendees will gain valuable insights into how these results could influence future research and treatment strategies. Don't miss this opportunity to enhance your understanding of this pivotal trial and its implications for clinical practice.

LEARNING OBJECTIVES

• Understand the Rationale: Review the design and purpose of the SELECT trial, focusing on its role in assessing the cardiovascular effects of obesity interventions.
• Analyze Key Findings: Discuss the primary outcomes of the SELECT trial, including its impact on cardiovascular events and overall mortality in patients with obesity.
• Evaluate Clinical Implications: Explore how the findings from the SELECT trial can influence clinical decision-making in the management of patients with obesity and cardiovascular risk factors.
• Discuss Future Directions: Identify potential future research areas based on the outcomes of the SELECT trial, particularly in obesity and cardiovascular disease prevention

FACULTY

Roberto I Mota Alvidrez, MD, MS, FAHA

Assistant Professor, Assistant ProfessorKL2 scholar

College of Pharmacy - Pharmaceutical Sciences

Ildiko Lingvay,  MD, MPH, MSCS

Professor of Medicine, Department of Internal Medicine/ Endocrinology 

Professor, Peter O'Donnell Jr School of Public Health

Medical Director,  Office of Clinical Trials Management 

UT Southwestern Medical Center at Dallas,  TX